Health Decisions is a Durham-based contract research organization that provides clinical research services, biostatistics and strategic consulting. The company has a dual focus, specializing in women’s health therapeutic clinical studies and diagnostics across therapeutic areas. Founded in 1989 by Michael Rosenberg, the firm continued operations after Rosenberg’s death in a 2014 plane crash. Chief Executive Officer Patrick Phillips has redoubled the company’s focus on women’s health and expanded its emphasis to a wider range of health-care products; Phillips previously served as vice president of clinical affairs and has overseen more than 200 regional and global clinical development projects. An SEC filing shows Health Decisions raised $1.8 million from 13 investors to allow the company to continue to provide clinical development expertise for women’s health with minimal risk. The article does not disclose revenue, valuation, or detailed terms of the investment.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2018